World's Best Scientists 2026 revealed!
Cancer Biology and Medicine
H-index 22

Cancer Biology and Medicine

2095-3941

Published by: Chinese Anti-cancer Association

http://www.cancerbiomed.org/index.php/cocr

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1581 51 54 16

Additional Metrics

Number of Best Scientists*: 127
Documents by Best Scientists*: 123
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 69
SCIMAGO SJR: 1.47
Impact Factor: 8.4

Overview

Top Research Topics at Cancer biology and medicine?

The main points discussed in Cancer biology and medicine deals with Cancer research, Cancer, Internal medicine, Oncology and Metastasis. Cancer research research featured in the journal incorporates concerns from various other topics such as Cell, Cell growth, Carcinogenesis, Apoptosis and Cancer cell. The concepts on Cancer presented in it can also apply to other research fields, including microRNA, Surgery, Immune system and Bioinformatics.

It focuses on Internal medicine as well as the interrelated topic of Gastroenterology. Cancer biology and medicine focuses on Oncology but the discussions also offer insight into other areas such as Clinical trial and Survival analysis. The majority of Hepatocellular carcinoma studies are focused on the issues of Liver cancer.

Chemotherapy research discussed connects with the study of Radiation therapy. The journal investigates Breast cancer research which frequently intersects with Pathology.

  • Cancer research (32.80%)
  • Cancer (28.84%)
  • Internal medicine (27.09%)

What are the most cited papers published in the journal?

  • Epidemiology of ovarian cancer: a review. (500 citations)
  • HOTAIR : an oncogenic long non-coding RNA in different cancers (260 citations)
  • Current approaches in treatment of triple-negative breast cancer (254 citations)

Research areas of the most cited articles at Cancer biology and medicine:

The most cited papers are organized to reinforce research efforts on Cancer, Cancer research, Internal medicine, Oncology and Metastasis. The published articles hold forums on Cancer that merge themes from other disciplines such as Adiponectin and Bioinformatics. While the most cited papers focused on Cancer research, they were also able to explore topics like Blockade, Signal transduction, Immunology and Long non-coding RNA.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Gene

The previous edition focused in particular on these issues:

Cancer biology and medicine investigates studies in Cancer research, Cancer, Internal medicine, Oncology and Metastasis. In the journal, Cell, Cell growth, Carcinogenesis, Apoptosis and Immune system are investigated in conjunction with one another to address concerns in Cancer research research. Cancer cell is a major topic of Cancer research presented in it.

Studies on Internal medicine discussed in the journal link to the field of Gastroenterology. The work on Oncology tackled in it brings together disciplines like Breast cancer, Anthracycline, Phases of clinical research and Proportional hazards model. It addresses concerns in Metastasis which are intertwined with other disciplines, such as Immunohistochemistry, Circular RNA, microRNA and Adenocarcinoma.

The most cited articles from the last journal are:

  • Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants. (10 citations)
  • Stimuli-responsive nanocarriers for therapeutic applications in cancer. (4 citations)
  • Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH -mutant glioblastoma. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer biology and medicine (based on the number of publications) are:

  • Xiubao Ren (9 papers) published 5 papers at the last edition, 3 more than at the previous edition,
  • Jinpu Yu (8 papers) published 2 papers at the last edition,
  • Feng Wei (7 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Niki Karachaliou (7 papers) absent at the last edition,
  • Rafael Rosell (7 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer biology and medicine (based on the number of publications) are:

  • Tianjin Medical University Cancer Institute and Hospital (99 papers) published 23 papers at the last edition, 8 more than at the previous edition,
  • Tianjin Medical University (51 papers) published 8 papers at the last edition, 5 more than at the previous edition,
  • Peking Union Medical College (44 papers) published 16 papers at the last edition, 5 more than at the previous edition,
  • Shanghai Jiao Tong University (37 papers) published 13 papers at the last edition, 6 more than at the previous edition,
  • Peking University (32 papers) published 12 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.44% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 60.47% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.08% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.83% of all publications and 11.63% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

How to Pursue a Career in Cancer Research

In order to pursue a career in cancer research, a solid knowledge base in topics relating to cancer biology and medicine is crucial. This can be obtained by obtaining an undergraduate degree in biological sciences and pursuing further studies in areas such as oncology, internal medicine or bioinformatics. It is advisable to participate actively in research studies and projects that aim to understand the causes, effects and possible solutions to cancer. Subspecialties in cancer research can also be explored including research in specific types of cancer such as breast cancer, liver cancer and more. For individuals interested in pursuing this career path online, there are several highly-rated online nursing programs available. One of the highly-ranked online courses is found on Research.com. The best online nursing programs in California offer comprehensive insights into nursing principles and techniques, which can then be applied in cancer research. These programs cater to both entry-level nurses as well as advanced nurses looking to specialize in a specific area. Besides academic skills, good analytical, problem-solving, and communication skills are also essential in this field. The passion to make a difference in the lives of cancer patients further fuels progress in this ever-evolving field. Pursuing a career in cancer research not only offers the chance to contribute to lifesaving research but also provides opportunities to work with some of the brightest minds in the medical scientific community.

Top Publications

  • Cancer burden in China: trends, risk factors and prevention

    Dianqin Sun;He Li;Maomao Cao;Siyi He

    (2020)
    174 Citations
  • Current cancer burden in China: epidemiology, etiology, and prevention

    (2022)
    164 Citations
  • Personalized immunotherapy in cancer precision medicine.

    Kazuma Kiyotani;Yujiro Toyoshima;Yusuke Nakamura

    (2021)
    81 Citations
  • Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data.

    Yufei Jiang;Huiyun Yuan;Zhuoying Li;Xiaowei Ji

    (2021)
    62 Citations
  • Current management of chemotherapy-induced neutropenia in adults: key points and new challenges

    Yi Ba;Yuankai Shi;Wenqi Jiang;Jifeng Feng

    (2020)
    60 Citations
  • Trispecific killer engager 161519 enhances natural killer cell function and provides anti-tumor activity against CD19-positive cancers

    Ying Cheng;Xiaodong Zheng;Xuefu Wang;Yongyan Chen

    (2020)
    31 Citations
  • Updates in endocrine therapy for metastatic breast cancer

    (2021)
    30 Citations
  • Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.

    Olivia Leblanc;Sophie Vacher;Charlotte Lecerf;Emmanuelle Jeannot

    (2020)
    30 Citations
  • Targeting PP2A for cancer therapeutic modulation

    (2022)
    24 Citations
  • Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells.

    Arsen Osipov;Alex B. Blair;Juliane Liberto;Jianxin Wang

    (2021)
    22 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge or advancing their career, exploring related online degrees can be highly beneficial. Many professionals choose to pursue a Doctor of Nursing Practice through the shortest dnp program, which offers an accelerated pathway to doctoral-level expertise without compromising quality.

Alternatively, individuals looking for quicker entry into healthcare roles may consider the accelerated cma program. This intensive course enables students to become certified medical assistants in as little as six weeks, opening doors to essential clinical support positions.

For registered nurses holding a Master of Science in Nursing, transitioning to a Doctor of Nursing Practice is streamlined through msn to dnp programs. These programs are designed to build on existing knowledge and experience, easing the completion of advanced nursing education.

Those interested in the administrative side of healthcare may find value in the cheapest medical billing and coding online courses. These affordable courses help learners gain the skills required for vital billing and coding jobs within healthcare facilities, often with flexible online options.

Best Scientists Contributing to This Journal